Blood test after CAR-T could spot returning cancer early
NCT ID NCT05675982
First seen Jan 06, 2026 · Last updated May 23, 2026 · Updated 22 times
Summary
This study looks at whether a blood test can quickly detect leftover cancer DNA in people treated with CAR-T cells for a type of lymphoma. About 40 adults will provide blood samples a week after treatment, and researchers will see if they can report results within three weeks. The goal is to find out if this early warning can help doctors act sooner if the cancer comes back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Henri Becquerel
Rouen, France
Conditions
Explore the condition pages connected to this study.